Citi Downgrades Relypsa, Inc. (RLYP) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Wall St rises as chip rally offsets renewed Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices slide over 1% as US-Iran conflict clouds Hormuz reopening
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
Galenica to acquire Relypsa to strengthen its Business unit Vifor Pharma
July 21, 2016 1:02 AM EDTVifor Pharma Ltd. / Galenica to acquire Relypsa to strengthen its Business unit Vifor Pharma . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Galenica and Relypsa announce agreement for Galenica to acquire Relypsa. Acquisition strengthens Galenica's Business unit, Vifor Pharma - an important step towards becoming an independent specialty pharma company... More
